[HTML][HTML] Using health technology assessment to assess the value of new medicines: results of a systematic review and expert consultation across eight European …
Background Although health technology assessment (HTA) systems base their decision
making process either on economic evaluations or comparative clinical benefit assessment …
making process either on economic evaluations or comparative clinical benefit assessment …
Assessing cost-effectiveness in healthcare: history of the $50,000 per QALY threshold
SD Grosse - Expert review of pharmacoeconomics & outcomes …, 2008 - Taylor & Francis
Cost–effectiveness analyses, particularly in the USA, commonly use a figure of 50,000perlife-
yearorquality-adjustedlife-yeargainedasathresholdforassessingthecost …
yearorquality-adjustedlife-yeargainedasathresholdforassessingthecost …
The influence of costeffectiveness and other factors on nice decisions
Abstract The National Institute for Health and Care Excellence (NICE) emphasises that cost
effectiveness is not the only consideration in health technology appraisal and is increasingly …
effectiveness is not the only consideration in health technology appraisal and is increasingly …
Rationing of total knee replacement: a cost-effectiveness analysis on a large trial data set
Objectives Many UK primary care trusts have recently introduced eligibility criteria restricting
total knee replacement (TKR) to patients with low pre-operative Oxford Knee Scores (OKS) …
total knee replacement (TKR) to patients with low pre-operative Oxford Knee Scores (OKS) …
Reimbursement decisions for pharmaceuticals in Sweden: the impact of disease severity and cost effectiveness
M Svensson, FOL Nilsson, K Arnberg - Pharmacoeconomics, 2015 - Springer
Abstract Objective The Swedish Dental and Pharmaceutical Benefits Agency (TLV) is the
government body responsible for deciding whether outpatient drugs are to be included in …
government body responsible for deciding whether outpatient drugs are to be included in …
The role of value for money in public insurance coverage decisions for drugs in Australia: a retrospective analysis 1994-2004
AH Harris, SR Hill, G Chin, JJ Li… - Medical Decision …, 2008 - journals.sagepub.com
Objective. To analyze the relative influence of factors in decisions for public insurance
coverage of new drugs in Australia. Data Sources. Evidence presented at meetings of the …
coverage of new drugs in Australia. Data Sources. Evidence presented at meetings of the …
Exploring the social value of healthcare interventions: a stated preference discrete choice experiment
Much of the literature on distributive preferences covers specific considerations in isolation,
and recent reviews have suggested that research is required to inform on the relative …
and recent reviews have suggested that research is required to inform on the relative …
[PDF][PDF] Health technology assessment: lessons learned from around the world—an overview
JC O'Donnell, SV Pham, CL Pashos, DW Miller… - Value in health, 2009 - core.ac.uk
Few recent issues in drug development and health systems management have generated
more commentary, and more controversy, than health technology assessment (HTA). The …
more commentary, and more controversy, than health technology assessment (HTA). The …